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Introduction
Cerebral ischemic stroke is one of the leading causes of death 
worldwide, carrying a significant disease burden as the second- 
leading cause of disability-adjusted life years1,2. Current approved 
treatment options are limited for acute ischemic stroke patients, 
involving either thrombolytic clot breakdown or physical clot 
removal. Recombinant tissue plasminogen activator (rtPA) 
is the only pharmacological treatment available with proven 
efficacy3,4, eligibility for this treatment is low and, due to a 
narrow therapeutic time window (<4.5 h), only ~15% of stroke 
patients are able to receive iv-rtPA treatment, with recanalisa-
tion success at less than 50%5,6. In addition to this, endovascu-
lar thrombectomy is increasingly being used in the treatment 
of large vessel occlusions, where the clot is removed from 
within the vessel allowing recanalisation, especially in patients 
who respond poorly to rtPA treatment5. Prompt restoration of 
blood flow to the ischemic zone is the primary clinical goal, 
potentially salvaging tissue and preventing the spread of ischemic 
damage7. Recanalization of occluded vessels is positively 
correlated with improved survival rates and recovery outcomes for 
ischemic stroke patients8.
To allow development of new clinical therapeutics for stroke, 
the pathophysiology and mechanisms of disease/recovery need 
to be elucidated. Preclinical stroke models that closely mimic 
mechanisms of injury (and recovery) allow investigation of 
potential clinically viable treatments. Although experimental 
stroke models have shown the positive benefits of various poten-
tial therapeutics, these have repeatedly failed during clinical 
trials, preventing their progression into the clinic. This continued 
lack of translation requires us to further refine preclinical studies 
and to allow the evolution of more representative models9,10.
The most commonly used experimental model of ischemic stroke 
is the intraluminal filament model of middle cerebral artery 
occlusion (MCAO). First developed by Koizumi et al.11 and 
later modified by Longa et al.12, with numerous minor variations 
to the model since then. These two models are widely used in 
preclinical experimental stroke research largely due to their mini-
mally invasive technique and ability to induce post-occlusion 
reperfusion13. However, although surgical procedures follow 
a defined protocol, lesion volumes have large standard 
deviations14–16. With the Koizumi method, permanent ligation of 
the common carotid artery (CCA) is required, preventing return 
of flow through the internal carotid artery (ICA), thus reper-
fusion is dependent on collateral flow via the Circle of Willis 
(CoW). However, the CoW in C57BL/6J mice, commonly used in 
preclinical stroke models, is anatomically variable which affects 
collateral flow ability17,18. In addition to this, there are adverse 
consequences to animal wellbeing when impacting the external 
carotid artery (ECA), either for vessel entry as in the Longa 
modified model or for surgical ease as seen in the original 
Koizumi model, such as lick impairment affecting ability to 
drink alongside increased weight loss19.
Stroke in the territory of the middle cerebral artery is the most 
common presentation seen in patients20, thus targeting this 
vessel in preclinical models is valid. However, clot lysis induced 
by rtPA treatment results in gradual reperfusion to the ischemic 
territory, whereas in the MCAO model, filament removal is 
sudden giving an immediate blood flow surge to the ischemic 
area21. In the clinic, endovascular thrombectomy allows physical 
removal of large vessel clots21,22, permitting rapid reflow through 
the previously occluded vessel, which is the primary clinical 
goal and parallels that which occurs in transient MCAO upon 
filament withdrawal. However, MCAO models where intralumi-
nal access is obtained via the CCA, such as the Koizumi method23, 
rely on collateral perfusion after filament removal due to the 
CCA being permanently tied off to prevent blood loss. Previously, 
we reported a modification to the Koizumi model of intraluminal 
filament MCAO, which allows bilateral CCA reperfusion, negat-
ing the reliance on the CoW10. In commonly used mice strains 
such as the C57BL/6J, the variability seen in lesion volume may 
be largely due to anatomical variations in the CoW17. Remov-
ing reperfusion reliance on the CoW reduces the variability seen 
in lesion volume but the impact on reperfusion is not known. 
Our aim here therefore is to determine if the adapted MCAO 
model can improve reperfusion following removal of the filament.
Methods
Animals
This study was conducted in accordance with the UK Ani-
mals (Scientific Procedures) Act, 1986, under Project license 
P28AA2253 following ethical approval from the University 
of Manchester. Animals were group housed (n=4) on arrival 
in temperature- and humidity-controlled individually venti-
lated mouse cages (IVCs) with a 12-h light/dark cycle, situated 
within a specific pathogen free (SPF) facility. Cages contained: 
woodchip bedding, paper sizzle nesting and cardboard tube. 
Animals were given adlib access to dry pellet food and water. 
Experimental sample size was determined using a power calcula-
tion from preliminary data (one tailed, α=0.001, β=0.9), taking 
into account a mortality rate of 10% established from historical 
MCAO data within our group. A total of 18 adult male C57BL/6J 
mice (10 weeks old on arrival; Charles River, UK), weighing 
22–33 g at the time of MCAO, were used during this study: two 
animals were excluded due to surgical complications, two due to 
reaching humane endpoints and one due to repeated wound com-
plications. All remaining animals (n=13) were humanely killed 
by cervical dislocation under anaesthesia following the 48-h 
post-MCAO scanning procedure. All experiments are reported 
in accordance with the Animal Research: Reporting of In Vivo 
Experiments (ARRIVE) guidelines 201824.
Study design
Individual animals were randomly assigned using an auto-
mated list randomiser (random.org) to one of two experimental 
groups: CCA ligation or CCA repair. The CCA ligation group 
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underwent 60 minutes transient MCAO with permanent CCA 
ligation following reperfusion25. The CCA repair group under-
went 60 minutes transient MCAO followed by repair of the CCA 
using a tissue pad and sealant combination, resulting in a patent 
CCA10. Both groups underwent laser speckle contrast imaging 
(LSCI). The order of coded LSCI raw data files was randomised 
prior to analysis using an automated list randomiser. The 
experimenter was blind to groups during LSCI scanning and 
image analysis for raw data, data was decoded for statistical 
analysis only.
Laser speckle contrast imaging
All animals underwent LSCI. Imaging was undertaken 12 
days prior to MCAO (baseline imaging), then at 24 h and 48 h 
post-MCAO (Figure 1A). Anaesthesia was induced and main-
tained with isoflurane (induction 5% in 100% O2; maintenance 
1.5% in N2O/O2, 70/30%), following which mice were placed 
in a stereotaxic frame on a heat mat set to 37°C. The animals 
were positioned underneath a moorFLPI2 Full-Field Perfusion 
Imager (Moor Instruments, UK). Prior to incision Bupivacaine 
hydrochloride (2 mg/kg, Marcain 0.25%, AstraZeneca, UK) 
local anaesthesia was injected subcutaneous around the intended 
incision site. A midline incision was made and skin retracted to 
expose the intact skull. Ultrasound gel was applied to the skull, 
followed by a 10-mm2 glass coverslip pressed down slightly 
to allow complete coverage of the intended scan area. LSCI was 
conducted for 3 min at 19 frames (20 ms per frame, 10-s intervals). 
The incision was cleaned free of ultrasound gel using sterile 
Figure 1. Cerebral blood flow measurements. Common carotid artery (CCA) vessel repair promotes cerebral blood flow (CBF) recovery 
following transient middle cerebral artery occlusion (MCAO). Regions of interest (ROIs) surrounding the ipsilateral and contralateral 
hemisphere were used to quantify CBF. (A) Representative LSCI images at baseline, 24 h and 48 h post-MCAO in CCA Ligated and CCA 
repair mice. Contra, contralateral hemisphere; Ipsi, ipsilateral hemisphere. (B) CBF obtained by LSCI, measured separately at baseline, 
24 h and 48 h post-MCAO, expressed as ipsilateral flux as a percentage of contralateral flux. Statistical analysis performed 
using two-way ANOVA followed by Sidak post-hoc (ns P ≥ 0.05, */X P ≤ 0.05, **/XX P ≤ 0.01, ***/XXX P ≤ 0.001). *Represents significance 
within experimental group versus Baseline. XRepresents significance between experimental groups. All data presented as mean ± SD (CCA 
Ligated n=7, CCA Repair n=6).
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swabs and flushed with sterile saline, the incision was sutured 
using subcutaneous 6-0 dissolvable sutures followed by tissue 
adhesive application (Vetbond, US). The animal was returned to 
a pre-warmed clean cage for recovery. Following baseline LSCI 
only, animals were given access to paracetamol (200 mg/kg/24 h; 
Calpol®, Johnson & Johnson Ltd UK) in jelly for 24 h for 
self-administration analgesia. LSCI images were analysed using 
moorFLPI2 Full-Field Laser Perfusion Imager Review v5.0 
software. For each animal, ipsilateral and contralateral hemi-
sphere ROIs were drawn, ROI flux data was obtained from each 
hemisphere for each of the 19 images per scan, the mean of 
these values was used in later analyses. Ipsilateral hemisphere 
cerebral blood flow (CBF) is expressed as a percentage of the 
contralateral hemisphere CBF, within each imaging session. 
All analysis was conducted blinded to experimental conditions.
Surgical procedure
All mice underwent transient MCAO as previously detailed, 
and surgical methods used were identical to those published 
previously by the author10,26, modified only to exclude Laser 
Doppler Flowmetry recording at MCAO reperfusion. MCAO 
was confirmed using laser doppler flowmetry (LDF), distin-
guished as a significant sustained drop in LDF flux once the 
microfilament filament was advanced into the internal carotid 
artery.
Statistical analysis
All data are expressed as mean ± standard deviation of the 
mean (SD). All statistical analysis was performed using Prism 
v8 for windows (GraphPad Software, CA). The criterion for 
statistical significance was P ≤ 0.05. Distribution of data was 
assessed using Shapiro-Wilk normality test, prior to statistical 
analysis. Repeated measure two-way analysis of variance 
(ANOVA) test was used to determine effect of time and inter-
vention, repair and ligation. Post-hoc Sidak corrected multiple 
comparison testing was then used to compare within groups 
against baseline/pre-MCAO, and within time point between 
groups.
Results
There was a significant interaction between the two factors, 
time and CCA incision closure method/intervention, suggest-
ing the effect of CCA intervention on CBF differs between the 
timepoints (F(2,22) = 17, P < 0.001; Figure 1B)). CCA interven-
tion post-MCAO, either ligation or repair, significantly affected 
ipsilateral CBF perfusion overall (F(1,11) = 7.4, P = 0.02). Mice 
that underwent CCA ligation showed significantly reduced ipsi-
lateral CBF compared to baseline (102.3 ± 4.57%) at 24 h (85.13 
± 16.09%; P = 0.001) and 48 h (75.04 ± 12.954%; P < 0.001) 
post-MCAO. Contrastingly, mice that underwent CCA repair 
showed no difference versus baseline (94.152 ± 2.44%) at 
24 h (102.83 ± 8.41%; P = 0.191) or 48 h (102.13 ± 9.34%; 
P = 0.251) post-MCAO. There was no difference in ipsilat-
eral CBF perfusion between groups at baseline (P = 0.417). 
At both 24 h and 48 h post-MCAO ipsilateral CBF was 
significantly increased in CCA repair mice compared to CCA 
ligated mice (P = 0.0122, P = 0.0001 respectively).
Discussion
Here we report CCA vessel repair following MCAO in mice 
results in improved reperfusion of the ischemic hemisphere, 
assessed using LSCI. Ligation of the CCA following MCAO fila-
ment removal significantly reduced perfusion to the ischemic 
hemisphere for a prolonged period post-surgery and the CBF did 
not return to baseline up to 48 h post-MCAO. Repair of the CCA 
incision, using a homologous tissue pad and TISSEEL sealant as 
previously reported10, returned hemispheric perfusion to pre-
MCAO baseline levels within 24 h post-MCAO. The use of CCA 
repair in mice has been shown to improve immediate MCA ter-
ritory blood flow within 5 minutes following repair and reduce 
lesion volume variability at 48 h post-MCAO10. Data here show 
the initial post-MCAO return to baseline CBF, as shown previ-
ously, is sustained during the acute phase (i.e. 48 h) with no evi-
dence of hypo or hyperperfusion in the ipsilateral hemisphere at 
24 and 48 h post-MCAO.
The data indicate CCA repair improves ischemic area perfusion 
post-MCAO, we assume this is due to the return to patency of 
the CCA removing the reliance on collateral flow through the 
CoW. The CoW has been shown in C57BL/6J mice to be ana-
tomically variable across individual animals17, adding variability 
to collateral supply to the ischemic area. Similarly, Smith et al. 
reported, using MCA territory laser doppler flowmetry to meas-
ure perfusion, significantly increased post-MCAO perfusion 
using the Longa ECA entry method with perfusion returning to 
comparable baseline levels, whereas use of the Koizumi CCA 
entry method showed only a return to 50% of baseline levels23. 
The key difference between the two methods is that the Longa 
method allows reperfusion through the bilateral CCAs whereas 
the Koizumi method relies on collateral supply to perfuse the 
ischemic area due to only the CCA being patent. These results 
mimic those reported here with CCA repair resulting in bilat-
erally patent CCAs leading to a return to baseline in perfusion 
post-MCAO. The use of a muscle pad combined with a fibrin 
sealant was previously shown in rat MCAO to allow forward 
blood flow through the CCA with complete occlusion of the 
vessel not present following the procedure27. Additionally, the 
CCA repair method ensures that the ECA remains in situ and 
patent, reducing the impact on animal welfare and recovery19.
Allowing reperfusion to occur through all available ves-
sels transforms the MCAO model to be more representative 
of clinical endovascular thrombectomy. Endovascular thrombec-
tomy is employed in an increasing number of clinical cases 
of large vessel occlusion (LVO), allowing mechanical, within 
vessel, removal of the occluding clot leading to a surge 
reperfusion of the ischemic zone, such as is seen following 
MCAO filament removal21. There is discussion in the literature 
as to the relevance of MCAO for modelling clinical stroke, 
due to the slow gradual clot dispersion that occurs following 
rtPA treatment, a mechanism unlike the sudden increase in flow 
seen at MCAO filament removal28, with suggestion that this 
slower clinical rtPA treatment reperfusion profile is closer to 
other embolic stroke models21,29. However, due to the positive 
effects of using endovascular thrombectomy for ischemic stroke 
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treatment, on blood flow and patient outcome, the intervention 
is likely to become the primary treatment for LVO21. With this 
in mind, there is renewed interest in the intraluminal filament 
model of MCAO as an established model of endovascular 
thrombectomy.
The data presented here suggest a beneficial effect on post- 
MCAO reperfusion in the ischemic hemisphere however, the 
limitations of our approach must be considered. LSCI has very 
good spatial and temporal resolution and is used to monitor CBF 
changes under both physiological and pathophysiological con-
ditions but it may be that the low penetration depth of the 
laser does not permit measurements of deep brain CBF but only 
allows imaging of surface and pial vessels30. This limits the 
interpretation of the data presented here, in terms of deep level 
reperfusion and further investigation would be required to 
assess the ability of CCA repair to improve deep level per-
fusion. In addition to this limitation, cerebral perfusion data is 
typically reported as raw arbitrary units or normalised to a 
baseline recording31,32, whereas the data reported here is 
presented as a % of the contralateral or non-ischemic hemi-
sphere. Often, MCAO experiments undertaking LSCI utilise 
continuous imaging pre and post-MCAO, preventing vari-
ability in animal/camera placement, focus level and instrument 
settings, improving the validity of obtained data and allow-
ing within experiment data normalisation/analysis. Due to 
the experimental design of this study, data was normalised 
within experiment to the non-stroke hemisphere, as reported 
previously33–36, to reduce the impact of between experiment 
variability from, for example equipment setup. However, it is 
important to note that this approach does not take into account 
the dynamic transhemispheric effect on CBF shown during 
focal ischemia reperfusion37. In addition to the expected CBF 
variations during and following MCAO, CBF in the contralateral 
hemisphere has also been reported to be affected during this 
pathology. The contralateral hemisphere is an important 
reserve to balance blood flow along the ischemic gradient to the 
ipsilateral hemisphere via collateral flow, particularly where 
reperfusion is reliant on flow from the basilar artery and con-
tralateral CCA18. It is also worthy to note that a sustained 
reduction in CBF measurements within the CCA ligated group 
is clear. This hypoperfusion could lead to exacerbation of post- 
stroke outcomes, with reduced oxygen levels resulting in path-
ological changes such as inflammation, demyelination and 
apoptosis38. Chronic sub-ischemic hypoperfusion is a key char-
acteristic of conditions such as vascular dementia and there is 
a strong clinical association between hypoperfusion and devel-
opment of vascular dementia39. In a further study it would be 
interesting to assess the impact of improved reperfusion on 
brain injury/recovery and functional outcome associated with 
ischemia.
In summary, this brief report shows that CCA repair following 
MCAO, in the mouse, using a homologous tissue pad combined 
with sealant improves blood flow to the ischemic hemisphere. 
The results validate the use of CCA repair in MCAO studies 
to remove reliance on the CoW avoiding the variation associ-
ated with this structure, in a commonly used mouse strain, on 
post-stroke measures. The outcome reported here may be 
of particular interest for use in endovascular thrombectomy 




Zenodo: Dataset corresponding to scientific paper “Improved 
reperfusion following alternative surgical approach for experimen-
tal stroke in mice”. https://doi.org/10.5281/zenodo.370123140.
This project contains the following underlying data: 
•    BASE_Repair (baseline raw LCSI export files for ani-
mals that underwent repair of the CCA; the three-symbol 
code at the start of each file represents a different 
mouse).
•    24h_Repair (24-hour raw LCSI export files for animals 
that underwent repair of the CCA; the three-symbol 
code at the start of each file represents a different mouse).
•    48h_Repair (48-hour raw LCSI export files for animals 
that underwent repair of the CCA; the three-symbol 
code at the start of each file represents a different mouse).
•    BASE_Ligated (baseline raw LCSI export files for 
animals that underwent ligation of the CCA; the three-
symbol code at the start of each file represents a 
different mouse).
•    24h_Ligated (24-hour raw LCSI export files for 
animals that underwent ligation of the CCA; the three-
symbol code at the start of each file represents a 
different mouse).
•    48h_Ligated (48-hour raw LCSI export files for 
animals that underwent ligation of the CCA; the three-
symbol code at the start of each file represents a 
different mouse).
•    20200206_F1000_LS_Manuscript Raw Data (LCSI 
Flux values obtained by drawing ROIs in the LSCI 
software and exporting the values).
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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